Therapeutic effect of pranlukast, a cysteinyl leukotriene receptor antagoist, on focal cerebral ischemia in mice

Chinese Pharmacological Bulletin

Volumn 20, Issue 7, 2004, Pages 758-761

  Xu, Qiu Qin ^b   Wei, Er Qing ^a   Yu, Yue Ping ^a   Zhang, Qi ^a   Zhang, Shi Hong ^a   Zhu, Chao Yang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HANGZHOU NORMAL UNIVERSITY   (China)

Author keywords

Brain edema; Cerebral ischemia; Cysteinyl leukotriene receptor antagonist; Pranlukast ONO 1078, 4 oxo 8 p (4 phenylbutyloxy) benzoyl amino 2 (tetrazol 5 yl) 4H 1 benzopyran hemihydrate ; edaravone (MCI 186, 3 methyl 1 phenyl 2 pyrazolin 5 one)

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; NORPHENAZONE; PRANLUKAST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HIPPOCAMPUS; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN;

EID: 5044236229     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Soberman RJ, Christmas P. The organization and consequences of eicosanoid signaling [J]. J Clin Invest, 2003, 111(8):1107-13.
2. Rao AM, Hatcher JF, Kindy MS et al. Arachickmic acid and leukotriene C4: role in transient cerebral ischemic of gerbils [J]. Neurochem Res, 1999, 24(10):1225-32.
3. Ciceri P, Rabuffetti M, Monopoli A et al. Production of leukotrienes in a model of focal cerebral ischaemia in the rat [J]. Br J Pharmacol, 2001, 133(8):1323-9.
4. Schuhmann MU, Mokhtarzadeh M, Stichtenoth DO et al. Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury [J]. Neurol Res, 2003, 25(5):481-91.
5. Wei EQ, Liu JW, Zhang LF et al. Effect of ONO-1078, a leukotriene anagonist, on capsaicin and substance P-induced broncho-constriction and airway microvascular leakage in guinea pigs [J]. Acta Pharmacol Sin, 1996, 17(3):209-12.
6. Brink C, Dahlen S-E, Drazen J et al. International union of pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors [J]. Pharmacol Rev, 2003, 55(1):195-227.
7. Zhang WP, Wei EQ, Mei RH et al. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats [J]. Acta Pharmacol Sin, 2002, 23(10):871-7.
8. Mao Y, Yang GY, Zhou LF et al. Focal cerebral ischemia in the mouse: Description of a model and effects of permanent and temporary occlusion [J]. Mol Brain Res, 1999, 63(2):366-70.
9. Bederson JB, Pitts LH, Tsuji M et al. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination [J]. Stroke, 1986, 17(3):472-6.
10. Yonemori F, Yamaguchi T, Yamada H et al. Evaluation of a motor deficit after chronic focal cerebral ischemia in rats [J]. J Cereb Blood Flow Metab, 1998, 18(8):1099-106.
11. Crumrine RC, Bergstrand K, Cooper AT et al. Lamotrigine protects hippocampal CA1 neurons from ischemia damage after cardiac arrest [J]. Stroke, 1997, 28(11):2230-7.
12. DeVries AC, Nelson RJ, Traystman RJ et al. Connitive and behavioral assessment in experimental stroke research: Will it prove usefull? [J]. Neurosci Biobehav Rev, 2001, 25:325-42.
13. Otomo E. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction [J]. Cerebrovasc Dis, 2003, 15(3):222-9.
14. Green AR, Odergren T, Ashwood T. Animal models of stroke: Do they have value for discovering neuroprotective agents? [J]. Trends Pharmacol Sci, 2003, 24(8):402-8.